Showing 2041 - 2050 of 3141 for "Pharmaceuticals and life sciences" with applied filters
04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU
Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.
03 January 2024 by Hui Ye Law Firm - China
Wu Dong of Hui Ye Law Firm discusses the key points necessary for understanding the foreign acquisition of Chinese state-owned enterprises
03 January 2024 by Ting ZHENG, Raymond YAN, Eryin YING, Lin ZHU
ESG is in high alignment with China’s “dual carbon” goals and has become an important indicator for measuring the sustainable and high-quality development of enterprises in China
03 January 2024 by Hui Ye Law Firm - China
Wu Dong and Sun Xiaoning from Hui Ye Law Firm highlight a number of considerations that warrant particular attention from foreign investors seeking to acquire state-owned enterprises in China.
02 January 2024 by Manisha Singh (Partner) & Avi Garg (Partner)
Non-patentable inventions are always a bone of contention between the applicant and the patent office.
02 January 2024 by Lee & Ko - South Korea
On December 19, 2023, the Korea Fair Trade Commission (“KFTC”) announced its proposal to enact the “Platform Competition Promotion Act” (“PCPA”) for ex-ante regulation of platforms by designating “dominant platform operators.”
21 December 2023 by Manisha Singh (Partner) & Neha Ruhela (Senior Associate)
The Delhi High Court, in F Hoffmann-La Roche & others v. Drugs Controller General of India & others (2023:DHC:6522), dismissed applications filed by Cadila Healthcare and Hetero Drugs seeking rejection of the plaints in Roche’s suits
15 December 2023 by VILAF - Vietnam
VILAF announces promotion of new partner Tung Nguyen
14 December 2023 by Yuen Law - Singapore : Tris Xavier
Singapore High Court determines that obligation to repay cryptocurrency counts as debts for determining the insolvency of a company under the Insolvency, Restructuring and Dissolution Act 2018
13 December 2023 by DPS Parmar
It is common to find competitive inventors to work on the uncovered aspect of a patent claim and design around it to escape the sword of infringement.
Register for FREE and enjoy the following benefits:
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com